Yajur Fibres (544676)
TurnaroundScore breakdown: P/E: 3/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹51.48 |
| Market Cap | ₹116.77 Cr |
| P/E Ratio | 9.83 |
| ROCE | 21.12% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | 0% |
| Debt/Equity | — |
| Sales Growth | 0% |
| Sector | Textiles & Apparels |
Strengths
- Trailing P/E of 9.83 is optically cheap if earnings normalize.
- Reported ROCE of 21.12% indicates decent backward-looking capital efficiency.
- Small market cap of ₹117 Cr gives scope for outsized returns if a genuine recovery occurs.
- Listing on NSE/BSE provides a regulated platform and disclosure standards.
Concerns
- Latest quarter sales and net profit are both ₹0 Cr, making the trailing P/E unreliable.
- Piotroski F-Score of 3/9 suggests weak financial health and possible deterioration.
- Critical data missing: book value, debt/equity, promoter holding, and 52-week range—so balance-sheet risk and governance cannot be assessed.
- No dividend and zero sales/profit growth provide neither income nor growth cushion.
AI Analysis
At ₹51.48, Yajur Fibres looks like the kind of small-cap that can either be a hidden treasure or a value trap. With a market cap of ₹117 Cr and a trailing P/E of 9.83, the market is pricing in some earnings power—roughly ₹11.9 Cr. But my first rule is to avoid losing money, and this balance sheet is too opaque for me to take that risk. Book value is unavailable, debt/equity unavailable, promoter holding unavailable, and the latest quarter shows sales of ₹0 Cr and net profit of ₹0 Cr. That alone destroys my confidence in the 9.83 P/E. I cannot rely on historical earnings when the current quarter is empty. On the positive side, ROCE of 21.12% suggests management has earned good returns on capital in some period. But returns on capital are only valuable if they are sustainable and supported by a competitive moat. I see no moat in ‘Other Textile Products’—a commodity, price-taking industry. The Piotroski F-score of 3/9 reinforces my caution; it points to weak financial health and possible deterioration. There is no dividend yield to compensate for waiting, and no growth in sales or profit. Graham would say price is what you pay, value is what you get. Here, I cannot calculate value because the data is incomplete. This is not an investment for me; it is a speculative situation requiring proof. I want to see several quarters of real sales and profits, clean debt numbers, and promoter skin in the game. Until then, the margin of safety is imaginary. I’d rather leave this in the ‘too hard’ pile and sleep well.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer